Mojgan Rahmaniyan, MD
Endocrinology, Diabetes & Metabolism · Greenville, SCNPI 1164407482
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations.
Across 313 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Abbott$567
- Dexcom, Inc.$552
- Insulet Corporation$519
- Novo Nordisk$417
- Sanofi-aventis U.S. LLC$406
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,16799%
- Education$901%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 87 | $1,186 |
| Abbott | 17 | $567 |
| Dexcom, Inc. | 20 | $552 |
| Insulet Corporation | 16 | $519 |
| Novo Nordisk | 15 | $417 |
| Sanofi-aventis U.S. LLC | 23 | $406 |
| Medtronic(2 entities) | 9 | $405 |
| Amneal Pharmaceuticals LLC | 17 | $268 |
| AstraZeneca(2 entities) | 16 | $246 |
| AbbVie | 12 | $172 |
| Boehringer Ingelheim | 10 | $150 |
| IBSA Pharma Inc. | 9 | $138 |
| Xeris Pharmaceuticals, Inc. | 7 | $134 |
| Radius Health, Inc. | 6 | $124 |
| Ascensia Diabetes Care US Inc. | 4 | $86 |
| Chiesi USA, Inc. | 4 | $78 |
| Merck | 5 | $76 |
| Tandem Diabetes Care, Inc. | 3 | $72 |
| Madrigal Pharmaceuticals | 3 | $69 |
| Recordati_rare_diseases_inc. | 3 | $66 |
| Pfizer | 3 | $63 |
| Amgen | 4 | $62 |
| Ultragenyx Pharmaceutical Inc. | 2 | $45 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
| Amphastar Pharmaceuticals, Inc. | 2 | $31 |
| Bayer | 2 | $30 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Cequr Corporation | 2 | $28 |
| BETA Bionics, Inc. | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Soleno Therapeutics, Inc. | 1 | $24 |
| EUSA Pharma (US) LLC | 1 | $22 |
| Sequel Med Tech, LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Mannkind Corporation | 1 | $18 |
| Lifescan, Inc. | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$149
- MINIMED 780G$143
- Minimed 670G System$126
- Omnipod$125
- DEXCOM G6 TRANSMITTER$123
- FreeStyle Libre 2$122
- DEXCOM G7 GSS (161)$120
- Tresiba$119
- DISEASE STATE$107
How this compares
$6,256 in reported general payments places this provider in the 65th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.
See all endocrinology, diabetes & metabolism providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $87,266 |
| TrulicityDulaglutide | 50 | $71,846 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 49 | $59,376 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 68 | $57,524 |
| Tresiba Flextouch U-100Insulin Degludec | 62 | $53,504 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 47 | $39,771 |
| SynthroidLevothyroxine Sodium | 657 | $37,431 |
| Novolog FlexpenInsulin Aspart | 100 | $30,709 |
| FarxigaDapagliflozin Propanediol | 21 | $28,159 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 116 | $26,545 |
| Gvoke Hypopen 2-PackGlucagon | 39 | $23,620 |
| Humalog Kwikpen U-100Insulin Lispro | 80 | $21,831 |
| MounjaroTirzepatide | 19 | $21,655 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 33 | $20,266 |
| JardianceEmpagliflozin | 15 | $14,513 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $1,186 | $93,50169 claims |
| Novo NordiskOzempic | $417 | $87,26669 claims |
| AbbVieSynthroid | $172 | $37,431657 claims |
| AstraZenecaFarxiga | $246 | $28,15921 claims |
| Boehringer IngelheimJardiance | $150 | $14,51315 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $268 | $7,6651,260 claims |
| PfizerLevoxyl | $63 | $3,728153 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.
Other endocrinology, diabetes & metabolism in Greenville
- Cory WhiteGreenville$413K
- James HortonGreenville$73K
- Sandra WeberGreenville$5K
- John BruchGreenville$4K
- Gregory SchleisGreenville$2K
- Gauri DhirMyrtle Beach$417K
- Louis HaenelCharleston$377K
- Vonda CalcuttWalterboro$368K
- Ray VaughtersAiken$321K
- Donald EagertonMyrtle Beach$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.